Breaking News
Freedom Does Not Mean Appointing New Taskmasters
Freedom Does Not Mean Appointing New Taskmasters
For Elon Musk's DOGE to Succeed, He Needs Ron Paul
For Elon Musk's DOGE to Succeed, He Needs Ron Paul
Top Tech News
Spinning fusion fuel for efficiency and Burn Tritium Ten Times More Efficiently
Rocket plane makes first civil supersonic flight since Concorde
Muscle-powered mechanism desalinates up to 8 liters of seawater per hour
Student-built rocket breaks space altitude record as it hits hypersonic speeds
Researchers discover revolutionary material that could shatter limits of traditional solar panels
In case you missed it, Ben Affleck just dropped the best talk on AI and where we're heading:
LG flexes its display muscle with stretchable micro-LED screen
LiFePO4 Charging Guidelines: What is 100%? What is 0%?! How to Balance??
Skynet On Wheels: Chinese Tech Firm Reveals Terrifying Robo-Dog
Energy company claims its new fusion technology can provide heat and power to 70,000 homes:
New blood, computer brains and frozen heads: How billionaires 'will live forever'
Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.